Mitchell Sinkler & Starr Eli Lilly & CO Transaction History

Mitchell Sinkler & Starr

$398 Million
Q1 2024

A detailed history of Mitchell Sinkler & Starr transactions in Eli Lilly & CO stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 3,802 shares of LLY stock, worth $3.57 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

3,802

Previous 14,161 73.15%

Holding current value

$3.57 Million

Previous $8.25 Million 64.17%

% of portfolio

0.74%

Previous 1.51%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $6.13 Million - $8.21 Million	-10,359 Reduced 73.15%	3,802 $2.96 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $3 Million - $3.53 Million	5,704 Added 67.45%	14,161 $8.25 Million
Q3 2023 Nov 01, 2023	BUY	$434.7 - $599.3 $2.69 Million - $3.71 Million	6,198 Added 274.37%	8,457 $4.54 Million
Q2 2023 Jul 18, 2023	SELL	$350.74 - $468.98 $89,087 - $119,120	-254 Reduced 10.11%	2,259 $1.06 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $247,572 - $290,761	-797 Reduced 24.08%	2,513 $863,000

Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $11,254 - $13,113	35 Added 1.07%	3,310 $1.21 Million
Q3 2022 Oct 25, 2022	SELL	$296.48 - $337.87 $126,004 - $143,594	-425 Reduced 11.49%	3,275 $1.06 Million
Q1 2022 Apr 19, 2022	BUY	$234.69 - $291.66 $224,833 - $279,410	958 Added 34.94%	3,700 $1.06 Million
Q4 2021 Feb 01, 2022	SELL	$224.85 - $279.04 $134,910 - $167,424	-600 Reduced 17.95%	2,742 $757,000
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $131,456 - $170,176	-800 Reduced 19.31%	3,342 $624,000
Q3 2020 Oct 07, 2020	SELL	$146.22 - $169.13 $228,103 - $263,842	-1,560 Reduced 27.36%	4,142 $613,000
Q1 2020 Apr 07, 2020	SELL	$119.05 - $147.35 $47,620 - $58,940	-400 Reduced 6.56%	5,702 $791,000
Q4 2019 Jan 09, 2020	SELL	$106.92 - $132.43 $150,757 - $186,726	-1,410 Reduced 18.77%	6,102 $802,000
Q2 2019 Jul 17, 2019	SELL	$110.79 - $129.32 $36,560 - $42,675	-330 Reduced 4.21%	7,512 $832,000
Q1 2019 Apr 08, 2019	SELL	$111.31 - $131.02 $63,001 - $74,157	-566 Reduced 6.73%	7,842 $1.02 Million
Q4 2018 Jan 24, 2019	SELL	$105.9 - $118.64 $281,482 - $315,345	-2,658 Reduced 24.02%	8,408 $973,000
Q2 2018 Jul 11, 2018	SELL	$75.7 - $86.88 $28,236 - $32,406	-373 Reduced 3.26%	11,066 $944,000
Q1 2018 Apr 13, 2018	BUY	$74.21 - $87.6 $848,888 - $1 Million	11,439 New	11,439 $885,000

Others Institutions Holding LLY

# of Institutions

3,728

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $893B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.

Account

Mitchell Sinkler & Starr Eli Lilly & CO Transaction History